[Prognostic value of IL-10 expression in tumor tissues of breast cancer patients].
To evaluate the prognostic value of IL-10 expression in breast cancer patients and determine the correlation between IL-10 expression and clinicopathological features of breast cancer. Paraffin sections were retrospectively collected from 130 patients of stage I-III breast cancer who received surgery between January 2000 and December 2002 in the Chinese PLA General Hospital. The protein expression of IL-10 in the primary lesions was detected by immunohistochemistry to analyze the correlations of IL-10 expression with clinicopathological variables and prognosis. IL-10 was found expressed in the cytoplasm of both tumor cells and stromal cells. Higher IL-10 expression in tumor cell cytoplasm was associated with lower T grade (P=0.012), higher SBR grade (P=0.004), positive ER (P=0.007), negative vascular invasion (P=0.034). The multivariant COX regression analysis showed that higher IL-10 expression in tumor cell cytoplasm was associated with better disease-free survival (HR=0.443, P=0.022) and that higher density of IL-10⁺; in stromal cell cytoplasm was associated with overall survival (HR=0.411, P=0.051). IL-10 expression level in breast tumor cells and stromal cells can be used as a predictor of breast cancer prognosis. Low expression of IL-10 is associated with poor survival outcome.